Production (Stage)
Achieve Life Sciences, Inc.
ACHV
$3.04
$0.072.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.45% | 0.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.78% | -2.21% | |||
| Operating Income | -5.78% | 2.21% | |||
| Income Before Tax | -3.78% | 1.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.78% | 1.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.78% | 1.21% | |||
| EBIT | -5.78% | 2.21% | |||
| EBITDA | -5.77% | 2.23% | |||
| EPS Basic | -3.27% | 1.67% | |||
| Normalized Basic EPS | -6.40% | 2.53% | |||
| EPS Diluted | -3.27% | 1.67% | |||
| Normalized Diluted EPS | -6.40% | 2.53% | |||
| Average Basic Shares Outstanding | 0.51% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||